liquid-hallmark-bg

Lucence at #ASCO21

Clarity in cancer care.

asco-banner-image1
news-image1 news-image2

News

Lucence shares real-world data on proprietary ultrasensitive amplicon-based sequencing assays at ASCO21.

From the CEO

Friends and colleagues,

Please join us for our second virtual ASCO program, from June 4-8, 2021. On this page you’ll find information on our latest news, our poster presentations, and information on how to book a meeting with our team, as well as instructions on how to register for our upcoming webinar happpening later this month.

Throughout this pandemic, Lucence has remained committed to advancing cancer care for the benefit of patients everywhere. We’re excited to share our work with you, and hope you’ll get in touch. Sign up here to make sure you receive the latest Lucence news and updates. For questions or assistance, do not hesitate to reach out to our team [email protected]. We’re looking forward to seeing you in person next year. Until then, we hope you’ll join us virtually.

Gratefully,

Min Han Tan

Narjust Duma

MD, Dana-Farber Cancer Institute

Tony Mok

MD, FRCPC, Chinese University of Hong Kong

Christine M. Lovly

MD, PhD, Vanderbilt Ingram Cancer Center

Gilberto Lopes

MD, MBA

Webinar: New Frontiers in Liquid Biopsy

  • 29 June 2021
  • 5:30 PM PST

Liquid biopsy is poised to transform from a cutting edge technology to a widely used clinical tool. Join us for a conversation among leading clinicians and researchers using liquid biopsy with patients as they discuss current applications and future directions.

poster-image2

Poster Presentations
and Abstracts for
ASCO 2021

4 June 2021

Authors: Wei Wu, Jing Shan Lim, Jonathan Poh, Trever G. Bivona; University of California, San Francisco, San Francisco, CA; Lucence Diagnostics, Singapore, Singapore; University of California San Francisco, San Francisco, CA

Abstract #3042

Poster number: #3042

4 June 2021

Authors: Jonathan Poh, Kao Chin Ngeow, Michelle Pek, Kian-Hin Tan, Jing Shan Lim, Yukti Choudhury; Lucence Diagnostics, Singapore, Singapore; Lucence Health, Palo Alto, CA

Abstract #3062

Poster number: #3062

Book a Meeting

Min-Han Tan, MBBS, PhD, FAMS CEO & Medical Director

Yukti Choudhury, PhD Chief Technology Officer

Jeffrey Dunklin VP, Commercial

Jack Challis, PhD VP, US Operations

Rita Melo-Nazareno, PharmD, PhD Medical Science Liaison

Get Updates

Sign up for the latest news and updates about Lucence at #ASCO21. For questions, email us at [email protected].